DSCR9 and familial pancreatic carcinoma: In this study, we found that lncRNA DSCR9 is downregulated in pancreatic cancer, and can modulate pancreatic cancer cell proliferation, invasion, and resistance to gemcitabine through lncRNA/miRNA/mRNA axis.